Project Grant R21TR005579
- Federal Grant Award Summary The National Science Foundation's Division of Civil, Mechanical, and Manufacturing Innovation awarded Georgia TECH Research Corp a $1,007,857 Project Grant (CFDA 47.041 - Engineering) effective August 1, 2025 through July 31, 2028 to develop an ultrasound-guided continuum (soft) robotic needle system for pediatric abdominal interventions. The project delivers fundamental research and technological innovations across three primary thrusts: (1) enhanced robot...
- Federal Project Grant Award Summary Georgia Tech Research Corporation received a $709,172 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through June 30, 2030. The award supports the development and validation of improved three-dimensional (3D) printed airway splints designed to treat tracheobronchomalacia (TBM), a congenital or acquired airway condition causing dynamic airway...
- Federal Project Grant Award Summary Georgia TECH Research Corp received a $603,818 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective April 1, 2026, with a completion date of March 1, 2030. The project focuses on developing a miniaturized combined intravascular ultrasound (IVUS) and fractional flow reserve (FFR)...
- Federal Grant Award Summary Georgia TECH Research Corp received a $418,284 Project Grant from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, effective September 1, 2025, through August 31, 2027, funds research and development of an ion-selective, sensor-integrated central venous catheter (CVC) system for real-time monitoring and automated correction of...
- Federal Project Grant Award Summary Georgia TECH Research Corp received a $1.113 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 3, 2025, with a completion date of April 30, 2029. This research initiative will develop and evaluate engineered biomaterials and targeted lipid nanoparticle delivery systems designed to enhance lymphatic regeneration and improve outcomes for lymphedema...
- Federal Project Grant Summary Georgia Tech Research Corporation received a $299,996 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 15, 2025, with completion targeted for June 30, 2029. The grant supports development of data-driven restless multi-armed bandit (RMAB) computational frameworks to optimize intervention allocation strategies for diabetes, cardiovascular disease, and maternal...
- Federal Grant Award Summary Georgia TECH Research Corp received a $200,000 Project Grant award from the National Science Foundation (NSF) Division of Mathematical Sciences under the Mathematical and Physical Sciences program (CFDA 47.049), effective September 15, 2025, with completion targeted for August 31, 2028. This collaborative research initiative focuses on developing and validating a comprehensive multi-physics mathematical model to improve understanding of radiofrequency ablation (RFA)...
- Federal Project Grant Award Summary Boston Children's Hospital received a $445,000 Project Grant award dated July 5, 2025, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project, titled "Ex Vivo and In Vivo Model Advancements for Airway Stent Design Optimization," will be conducted through May 31, 2028, at the hospital's Massachusetts...
- Federal Grant Award Summary Georgia TECH Research Corp received a $396,406 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), awarded May 1, 2026, with completion targeted for April 30, 2029. The award supports development of an Inverted Human Intraductal (IHIND) model—an in vitro breast cancer progression platform designed to improve upon existing preclinical models by utilizing all human cells in a high-throughput...
- Federal Grant Award Summary Georgia TECH Research Corp received a $410,864 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 19, 2026, with completion targeted for January 31, 2028. The research investigates mechanosensing mechanisms through the B cell antigen receptor (BCR), focusing on fundamental immunological processes governing B lymphocyte maturation, activation,...
Georgia TECH Research Corp received a $416,231 Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) effective May 1, 2026 through April 30, 2028. The award funds the development of a robotic bronchoalveolar lavage (ROBOBAL) device designed to improve diagnostic yield for pulmonary complications in critically ill children. The ROBOBAL system will feature a 3.25mm robotically steerable catheter with integrated camera and light source, coupled with a 1.2mm actively steerable working channel for fluid suction and irrigation. This innovation addresses a critical clinical gap by enabling access to distal airways beyond current diagnostic capabilities, specifically the fourth tracheobronchiole division compared to the current third division limitation, thereby reducing the fluid volume required during diagnostic procedures. The project encompasses two primary objectives: (1) design and development of the 3.25mm robotically steerable BAL device with advanced visualization and working channel capabilities, and (2) validation testing using five human cadaver lungs to compare diagnostic yield and fluid retention between the ROBOBAL system and standard-of-care BAL procedures. By improving clinician access to distal infection sites and inaccessible lung segments such as the right upper lobe, the ROBOBAL device is intended to enhance diagnostic accuracy while reducing morbidity associated with high-volume lavage procedures in pediatric critical care populations where pulmonary reserve is minimal.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $416.2k | 4/28/26 |